Literature DB >> 10946885

The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke.

M Carlsson1, M Orho-Melander, J Hedenbro, P Almgren, L C Groop.   

Abstract

To test the hypothesis that the A/T polymorphism of the fatty acid-binding protein 2 gene (FABP2) is associated with impaired lipid metabolism and cardiovascular disease, we compared clinical characteristics and a parental history of cardiovascular disease between 213 sibling pairs discordant for the polymorphism. Siblings with an excess of the T54 allele had higher triglyceride (P = 0.002) and cholesterol (P = 0.019) concentrations than siblings with the A54 allele. Parents of offspring with the T54T and T54A genotypes reported an increased prevalence of stroke compared to parents of offspring with the A54A genotype (P = 0.007). In summary, we have confirmed the association of the FABP2 T54 allele with increased concentrations of cholesterol and triglycerides in genotype-discordant sibling pairs. We also present novel evidence that genetic variation in the FABP2 gene may increase susceptibility to stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946885     DOI: 10.1210/jcem.85.8.6751

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients.

Authors:  D A de Luis; R Aller; O Izaola; M Gonzalez Sagrado; R Conde
Journal:  J Endocrinol Invest       Date:  2013-06       Impact factor: 4.256

2.  Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients.

Authors:  D A de Luis; M Gonzalez Sagrado; R Aller; O Izaola; R Conde; Enrique Romero
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

Review 3.  Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus.

Authors:  Shania Abbas; Syed Tasleem Raza; Faisal Ahmed; Absar Ahmad; Saliha Rizvi; Farzana Mahdi
Journal:  J Biomed Sci       Date:  2013-10-25       Impact factor: 8.410

4.  Polymorphism Ala54Thr of fatty acid-binding protein 2 gene is not associated with stroke risk in Han population of Hunan China.

Authors:  Yanmin Song; Yinxi Long; Lili Long; Ning Zhang; Yunhai Liu
Journal:  Med Sci Monit       Date:  2014-09-29

5.  Polymorphism of FABP2 and PPARG2 genes in risk prediction of cataract among North Indian population.

Authors:  Shania Abbas; Syed Tasleem Raza; Anu Chandra; Luxmi Singh; Saliha Rizvi; Ale Eba; Faisal Ahmed; Farzana Mahdi
Journal:  Meta Gene       Date:  2014-04-17

6.  The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile.

Authors:  Alireza Pasdar; Ghasem Yadegarfar; Alastair Cumming; Lawrence Whalley; David St Clair; Mary-Joan MacLeod
Journal:  BMC Med Genet       Date:  2007-06-06       Impact factor: 2.103

7.  Adaptations to climate in candidate genes for common metabolic disorders.

Authors:  Angela M Hancock; David B Witonsky; Adam S Gordon; Gidon Eshel; Jonathan K Pritchard; Graham Coop; Anna Di Rienzo
Journal:  PLoS Genet       Date:  2008-02       Impact factor: 5.917

8.  Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.

Authors:  Laura C Gomez; Sebastián M Real; Marta S Ojeda; Sergio Gimenez; Luis S Mayorga; María Roqué
Journal:  BMC Med Genet       Date:  2007-06-26       Impact factor: 2.103

9.  A54T polymorphism in the fatty acid binding protein 2 studies in a Saudi population with type 2 diabetes mellitus.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Mohammad D Bazzi; Nasser M Al-Daghri; Tarique N Hasan; May Salem Alnbaheen; Fawiziah Khalaf Alharbi; Yazeed A Al-Sheikh; Rabbani Syed; Mourad Am Aboul-Soud
Journal:  Lipids Health Dis       Date:  2014-04-01       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.